➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Medtronic
McKesson
Moodys
Harvard Business School

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Uswm Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for USWM, and what generic and branded alternatives to USWM drugs are available?

USWM has four approved drugs.



Summary for Uswm
US Patents:0
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Uswm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Uswm REVONTO dantrolene sodium INJECTABLE;INJECTION 078378-001 Jul 24, 2007 AP RX No No   Start Trial   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Uswm MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 207032-001 May 3, 2019 DISCN No No   Start Trial   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 AB RX Yes No   Start Trial   Start Trial
Uswm LUCEMYRA lofexidine hydrochloride TABLET;ORAL 209229-001 May 16, 2018 RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Uswm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Uswm CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 3,935,267   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,935,267   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 3,982,021   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 3,935,267   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 3,982,021   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 3,982,021   Start Trial
Uswm CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 3,935,267   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Express Scripts
Mallinckrodt
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.